EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
8.35
-0.61 (-6.76%)
Nov 21, 2024, 4:00 PM EST - Market closed
EyePoint Pharmaceuticals Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$27.29
Upside
+226.83%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $22 | Strong Buy | Maintains | $30 → $22 | +163.47% | Nov 11, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $28 → $33 | Strong Buy | Maintains | $28 → $33 | +295.21% | Nov 8, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $28 | Strong Buy | Maintains | $28 | +235.33% | Oct 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +259.28% | Oct 25, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $18 | Buy | Initiates | $18 | +115.57% | Oct 16, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +79.64% | Aug 28, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $32 → $29 | Buy | Maintains | $32 → $29 | +247.31% | Aug 13, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $28 | Strong Buy | Maintains | $28 | +235.33% | Jun 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +259.28% | Jun 27, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $35 → $32 | Buy | Maintains | $35 → $32 | +283.23% | Jun 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 → $30 | Strong Buy | Maintains | $33 → $30 | +259.28% | May 13, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $39 → $28 | Strong Buy | Maintains | $39 → $28 | +235.33% | May 7, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $39 → $30 | Strong Buy | Maintains | $39 → $30 | +259.28% | May 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +295.21% | Mar 8, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $30 → $39 | Strong Buy | Maintains | $30 → $39 | +367.07% | Feb 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.